| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T7 |
0-197 |
Sentence |
denotes |
Invasive pulmonary aspergillosis (IPA) is a well-known complication in immunocompromised patients and is encountered frequently in haematopoietic stem cell or solid organ transplant recipients [2]. |
| T8 |
198-345 |
Sentence |
denotes |
Continued improvement in diagnostics has revealed that half of the cases of IPA occur in the ICU, in patients who are often non-neutropenic [3, 4]. |
| T9 |
346-514 |
Sentence |
denotes |
Severe influenza infection is a well-known risk factor for developing IPA in non-neutropenic patients; a syndrome termed influenza-associated aspergillosis (IAA) [4–6]. |
| T10 |
515-673 |
Sentence |
denotes |
A damaged respiratory epithelium, dysfunctional mucociliary clearance and a local immune paralysis were demonstrated to be key pathophysiological factors [4]. |
| T11 |
674-850 |
Sentence |
denotes |
Supported by the hypothesis that alveolar damage facilitates fungal invasion, acute respiratory distress syndrome (ARDS) has frequently been associated with IPA in the ICU [6]. |
| T12 |
851-948 |
Sentence |
denotes |
With this in mind, the existence of COVID-19-associated pulmonary aspergillosis is deemed likely. |
